Evidence map›Paper›PMID 42045369›Full record

ArticleNature microbiology2026

Nuclease-NTPase antiphage defence systems use conserved molecular features to control bacterial immunity.

Adelyn E Ragucci, Sadie P Antine, Ethan M Leviss, Sarah E Mooney, Jasmine M Garcia, Lena Shyrokova, Vasili Hauryliuk, Amy S Y Lee, Philip J Kranzusch

Abstract read
PubMed Publisher
In one paragraph

Article in Nature microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adelyn E Ragucci *Department of Microbiology, Harvard Medical School, Boston, MA, USA.
Sadie P Antine *Department of Microbiology, Harvard Medical School, Boston, MA, USA.
Ethan M LevissDepartment of Microbiology, Harvard Medical School, Boston, MA, USA.
Sarah E MooneyDepartment of Microbiology, Harvard Medical School, Boston, MA, USA.
Jasmine M GarciaDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
Lena ShyrokovaDepartment of Experimental Medical Science and NanoLund, Lund University, Lund, Sweden.
Vasili HauryliukDepartment of Experimental Medical Science and NanoLund, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0003-2389-5057
Amy S Y LeeDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
Philip J KranzuschDepartment of Microbiology, Harvard Medical School, Boston, MA, USA. philip_kranzusch@dfci.harvard.edu.ORCID http://orcid.org/0000-0002-4943-733X

Funding

Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) 1DP2GM146250-01
6 · The paper itself

Abstract

Bacteria encode diverse defence systems, including restriction-modification and CRISPR-Cas, that cleave nucleic acid to protect against phage infection. Bioinformatic analyses demonstrate that many recently identified antiphage defence operons comprise a nuclease and NTPase protein, suggesting that additional nucleic acid-targeting systems remain to be understood. Here we develop large-scale comparative cell biology and biochemical approaches to analyse 16 nuclease-NTPase systems and define molecular features that control antiphage defence. Purification, biochemical characterization and in vitro reconstitution of nucleic acid degradation demonstrates that protein-protein complex formation is a shared feature of multigene nuclease-NTPase systems. We show that PaAbpAB, BtHachiman and EcPD-T4-8 system nucleases use highly degenerate recognition site preferences to enable broad nucleic acid degradation, and the Azaca system exhibits specific phage targeting through the recognition of modified phage genomic DNA. Our results uncover principles of antiphage defence system function and highlight the mechanistic diversity of nuclease-NTPase systems in bacterial immunity.

Indexed as

BacteriaBacteriophagesBacterial ProteinsBacterial Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.